Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.
RECRUITINGINTERVENTIONAL

Women Focused Encounters for Resilience Independence Strength and Eudaimonia

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.

About This Trial

The goal of this combination Type 1 hybrid and observational study is to evaluate the impact of a peer delivered intervention of acceptance and comittment therapy(ACT) + exercise + social support to address the substance (ab)use, violence, and AIDS/HIV (SAVA) to improve medication adherence for women living with HIV (WLWH). This intervention will be implemented by community based organizations that focus on WLWH across four counties. The main question it aims to answer are: * Will peer provision of ACT, exercise, and social support improve medication adherence for WLWH? * Will community based organizations be able to sustain the intervention after research is completed, and what changes will need to be made to sustain th eintervention.

Who May Be Eligible (Plain English)

Who May Qualify: 1. Is female sex at birth (cis-women) 2. Able to read and understand English 3. Able to participate in a low intensity exercise program 4. HIV-seropositive 5. At risk substance use (any illegal or unprescribed drug), tobacco, marijuana or alcohol use (four or more drinks in one day or 8 or more in one week). 6. Reports missing more ART doses than previous months, or \> 5 in a month, or has a detectable HIV viral load 7. Experienced interpersonal violence 8. Able and willing to provide willing to sign a consent form 9. Confirmed COVID-19 vaccinated x 2 or willingness to wear a mask during inperson interactions. Who Should NOT Join This Trial: 1. Unwilling to participate in video record sessions (used to evaluate the quality of the intervention) 2. Enrolled in hospice 3. Not willing or not able to comply with study advisory board group participation agreement. Always talk to your doctor about whether this trial is right for you.

Original Eligibility Criteria

View original clinical language
Inclusion Criteria: 1. Is female sex at birth (cis-women) 2. Able to read and understand English 3. Able to participate in a low intensity exercise program 4. HIV-seropositive 5. At risk substance use (any illegal or unprescribed drug), tobacco, marijuana or alcohol use (four or more drinks in one day or 8 or more in one week). 6. Reports missing more ART doses than previous months, or \> 5 in a month, or has a detectable HIV viral load 7. Experienced interpersonal violence 8. Able and willing to provide informed consent 9. Confirmed COVID-19 vaccinated x 2 or willingness to wear a mask during inperson interactions. Exclusion Criteria: 1. Unwilling to participate in video record sessions (used to evaluate the quality of the intervention) 2. Enrolled in hospice 3. Not willing or not able to comply with study advisory board group participation agreement.

Treatments Being Tested

BEHAVIORAL

Acceptance and Commitment Therapy (ACT)

Participants will undergo ACT in combination with exercise and social support.

BEHAVIORAL

Body weight circuit training

Participants will learn and undergo body weight circuit training in combination with ACT and social support.

BEHAVIORAL

Empathetic social support

Study participants will participate in empathetic social support

OTHER

Control - list of resources

A local list of resources to access exercise, therapy and social support will be provided.

Locations (1)

UC San Diego AntiViral Research Center (AVRC)
San Diego, California, United States